Glen Eagle Advisors’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37 Buy
+2
New +$43 ﹤0.01% 1077
2025
Q4
Sell
-2
Closed -$48 1052
2025
Q3
$48 Buy
+2
New +$47 ﹤0.01% 1107
2024
Q2
Sell
-2
Closed -$66 1143
2024
Q1
$66 Hold
2
﹤0.01% 1084
2023
Q4
$73 Hold
2
﹤0.01% 1017
2023
Q3
$73 Hold
2
﹤0.01% 1010
2023
Q2
$77 Buy
+2
New +$74 ﹤0.01% 1046
2022
Q3
Sell
-2
Closed -$59 1093
2022
Q2
$59 Buy
+2
New +$67 ﹤0.01% 990
2021
Q1
Sell
-7
Closed -$243 1005
2020
Q4
$243 Hold
7
﹤0.01% 956
2020
Q3
$121 Buy
+7
New +$122 ﹤0.01% 900
2018
Q1
Sell
-3,216
Closed -$253K 681
2017
Q4
$253K Buy
+3,216
New +$259K 0.22% 109

Other funds holding ADNT

Glen Eagle Advisors's ADNT Position: Q2 2026 in Review

Glen Eagle Advisors opened a new position in Adient (ADNT) in Q2 2026: 2 shares worth $37. The stake represents ﹤0.01% of the portfolio and ranks #1077 among its holdings. This is a return to the name: Glen Eagle Advisors previously reported a position in ADNT as recently as Q3 2025.

Glen Eagle Advisors first reported a position in ADNT in Q4 2017 and has held it in 10 quarters since. The position peaked at $253K in Q4 2017. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Glen Eagle Advisors held 2 shares of Adient worth $37 as of Q2 2026.
  • Adient was a new Glen Eagle Advisors position in Q2 2026.
  • Adient made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #1077 holding.
  • Glen Eagle Advisors first reported a position in Adient in Q4 2017 and has held it in 10 quarters since.
  • Glen Eagle Advisors's Adient position peaked at $253K in Q4 2017.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.